Handel Abbott Laboratories - ABT CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.18 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.025457% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.003235% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Abbott Laboratories ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 102.04 |
Åben* | 102.57 |
1-Års Ændring* | -9.29% |
Dagens Spænd* | 102.34 - 103.24 |
52-Ugers Spænd | 93.25-118.23 |
Gennemsnitlig Volumen (10 dage) | 4.15M |
Gennemsnitlig Volumen (3 måneder) | 111.04M |
Market Cap | 178.89B |
P/E-forhold | 31.19 |
Udestående aktier | 1.74B |
Omsætning | 41.51B |
EPS | 3.30 |
Dividend (Udbytte %) | 1.98309 |
Beta | 0.66 |
Næste indtjeningsopgørelse | Jul 18, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 102.79 | 0.80 | 0.78% | 101.99 | 103.38 | 101.43 |
May 25, 2023 | 102.04 | -0.75 | -0.73% | 102.79 | 103.24 | 101.17 |
May 24, 2023 | 103.95 | -1.50 | -1.42% | 105.45 | 105.45 | 103.87 |
May 23, 2023 | 105.62 | -1.41 | -1.32% | 107.03 | 107.40 | 105.35 |
May 22, 2023 | 108.13 | 0.15 | 0.14% | 107.98 | 109.24 | 107.92 |
May 19, 2023 | 108.81 | 0.93 | 0.86% | 107.88 | 109.88 | 107.88 |
May 18, 2023 | 108.40 | 0.38 | 0.35% | 108.02 | 108.76 | 107.54 |
May 17, 2023 | 108.69 | -1.06 | -0.97% | 109.75 | 109.81 | 107.72 |
May 16, 2023 | 109.28 | 0.52 | 0.48% | 108.76 | 110.37 | 108.71 |
May 15, 2023 | 109.72 | -0.32 | -0.29% | 110.04 | 110.82 | 109.32 |
May 12, 2023 | 110.36 | 1.14 | 1.04% | 109.22 | 110.46 | 109.12 |
May 11, 2023 | 109.92 | -0.15 | -0.14% | 110.07 | 110.31 | 109.16 |
May 10, 2023 | 110.60 | 0.42 | 0.38% | 110.18 | 110.87 | 109.48 |
May 9, 2023 | 110.17 | 0.71 | 0.65% | 109.46 | 110.95 | 109.10 |
May 8, 2023 | 110.78 | 0.42 | 0.38% | 110.36 | 111.50 | 109.79 |
May 5, 2023 | 111.15 | 0.45 | 0.41% | 110.70 | 111.66 | 110.70 |
May 4, 2023 | 110.78 | 0.09 | 0.08% | 110.69 | 111.40 | 110.12 |
May 3, 2023 | 111.61 | -0.16 | -0.14% | 111.77 | 112.83 | 110.69 |
May 2, 2023 | 111.37 | 0.71 | 0.64% | 110.66 | 111.84 | 110.29 |
May 1, 2023 | 110.93 | 0.76 | 0.69% | 110.17 | 111.49 | 109.66 |
Abbott Laboratories Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
Tuesday, July 18, 2023 | ||
Tid (UTC) (UTC) 12:30 | Land US
| Begivenhed Q2 2023 Abbott Laboratories Earnings Release Q2 2023 Abbott Laboratories Earnings ReleaseForecast -Previous - |
Tuesday, October 17, 2023 | ||
Tid (UTC) (UTC) 12:30 | Land US
| Begivenhed Q3 2023 Abbott Laboratories Earnings Release Q3 2023 Abbott Laboratories Earnings ReleaseForecast -Previous - |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total omsætning | 43653 | 43075 | 34608 | 31904 | 30578 |
Omsætning | 43653 | 43075 | 34608 | 31904 | 30578 |
Kost af omsætning, Total | 19083 | 18490 | 14967 | 13196 | 12691 |
Bruttofortjeneste | 24570 | 24585 | 19641 | 18708 | 17887 |
Totale Driftsudgifter | 35336 | 34650 | 29136 | 27435 | 27095 |
Salgs/Generelle/Admin. Udgifter, Total | 11109 | 11217 | 9676 | 9694 | 9691 |
Forskning & Udvikling | 2741 | 2733 | 2403 | 2408 | 2288 |
Depreciation / Amortization | 2013 | 2047 | 2132 | 1936 | 2178 |
Usædvanlig Udgift (Indkomst) | 390 | 163 | -42 | 201 | 247 |
Driftsindtægter | 8317 | 8425 | 5472 | 4469 | 3483 |
Renteindkomst (Udgift), Netto Ikke-Drift | -377 | -491 | -492 | -583 | -749 |
Andre, Netto | 366 | 277 | -12 | 191 | 139 |
Netto Indkomst Før Skat | 8306 | 8211 | 4968 | 4077 | 2873 |
Netto Indkomst Efter Skat | 6933 | 7071 | 4497 | 3601 | 2464 |
Netto Indkomst Før Ekstra Ting | 6933 | 7071 | 4497 | 3601 | 2464 |
Totale Ekstraordinære Ting | 0 | -2 | 86 | -96 | |
Netto Indkomst | 6933 | 7071 | 4495 | 3687 | 2368 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 6933 | 7071 | 4497 | 3601 | 2464 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 6933 | 7071 | 4495 | 3687 | 2368 |
Fortyndet Netto Indkomst | 6933 | 7071 | 4495 | 3687 | 2368 |
Fortyndet Vægtet Gennemsnit Aktier | 1764 | 1789 | 1786 | 1781 | 1770 |
Fortyndet EPS Uden Ekstraordinære Ting | 3.93027 | 3.95249 | 2.51792 | 2.0219 | 1.39209 |
Dividends per Share - Common Stock Primary Issue | 1.88 | 1.8 | 1.44 | 1.28 | 1.12 |
Fortyndet Normaliseret EPS | 4.11623 | 4.03095 | 2.49663 | 2.12158 | 1.51177 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total omsætning | 9747 | 10091 | 10410 | 11257 | 11895 |
Omsætning | 9747 | 10091 | 10410 | 11257 | 11895 |
Kost af omsætning, Total | 4325 | 4593 | 4629 | 4933 | 4987 |
Bruttofortjeneste | 5422 | 5498 | 5781 | 6324 | 6908 |
Totale Driftsudgifter | 8238 | 8787 | 8640 | 8881 | 8983 |
Salgs/Generelle/Admin. Udgifter, Total | 2751 | 2973 | 2731 | 2757 | 2787 |
Forskning & Udvikling | 654 | 725 | 671 | 684 | 697 |
Depreciation / Amortization | 491 | 496 | 498 | 507 | 512 |
Usædvanlig Udgift (Indkomst) | 17 | 0 | 111 | ||
Driftsindtægter | 1509 | 1304 | 1770 | 2376 | 2912 |
Renteindkomst (Udgift), Netto Ikke-Drift | -58 | -52 | -105 | -106 | -114 |
Andre, Netto | 111 | 68 | 93 | 82 | 78 |
Netto Indkomst Før Skat | 1562 | 1320 | 1758 | 2352 | 2876 |
Netto Indkomst Efter Skat | 1318 | 1033 | 1435 | 2018 | 2447 |
Netto Indkomst Før Ekstra Ting | 1318 | 1033 | 1435 | 2018 | 2447 |
Totale Ekstraordinære Ting | |||||
Netto Indkomst | 1318 | 1033 | 1435 | 2018 | 2447 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 1318 | 1033 | 1435 | 2018 | 2447 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 1318 | 1033 | 1435 | 2018 | 2447 |
Fortyndet Netto Indkomst | 1318 | 1033 | 1435 | 2018 | 2447 |
Fortyndet Vægtet Gennemsnit Aktier | 1751.71 | 1752.46 | 1763.65 | 1765.46 | 1774.54 |
Fortyndet EPS Uden Ekstraordinære Ting | 0.75241 | 0.58946 | 0.81365 | 1.14304 | 1.37895 |
Dividends per Share - Common Stock Primary Issue | 0.51 | 0.47 | 0.47 | 0.47 | 0.47 |
Fortyndet Normaliseret EPS | 0.76059 | 0.58946 | 0.86503 | 1.14304 | 1.37895 |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 25224 | 24239 | 20441 | 15667 | 14632 |
Likvider og Kortsigtede Investeringer | 10170 | 10249 | 7148 | 4140 | 4086 |
Likvider & Lignende | 9882 | 9799 | 6838 | 3860 | 3844 |
Kortsigtede Investeringer | 288 | 450 | 310 | 280 | 242 |
Totale Tilgodehavender, Netto | 6218 | 6487 | 6414 | 5425 | 5182 |
Accounts Receivable - Trade, Net | 6218 | 6487 | 6414 | 5425 | 5182 |
Total Inventory | 6173 | 5157 | 5012 | 4316 | 3796 |
Prepaid Expenses | 2663 | 2346 | 1867 | 1638 | 1445 |
Other Current Assets, Total | 148 | 123 | |||
Total Assets | 74438 | 75196 | 72548 | 67887 | 67173 |
Property/Plant/Equipment, Total - Net | 10278 | 10112 | 10130 | 8972 | 7563 |
Property/Plant/Equipment, Total - Gross | 21328 | 20517 | 19894 | 17733 | 15706 |
Accumulated Depreciation, Total | -11050 | -10405 | -9764 | -8761 | -8143 |
Goodwill, Net | 22799 | 23231 | 23744 | 23195 | 23254 |
Intangibles, Net | 10454 | 12739 | 14784 | 17025 | 18942 |
Long Term Investments | 766 | 816 | 821 | 883 | 897 |
Other Long Term Assets, Total | 4917 | 4059 | 2628 | 2145 | 1885 |
Total Current Liabilities | 15489 | 13105 | 11907 | 10863 | 9012 |
Accounts Payable | 4607 | 4408 | 3946 | 3252 | 2975 |
Accrued Expenses | 7401 | 6806 | 6581 | 5183 | 4867 |
Notes Payable/Short Term Debt | 0 | 0 | 213 | 201 | 200 |
Current Port. of LT Debt/Capital Leases | 2251 | 754 | 7 | 1277 | 7 |
Other Current Liabilities, Total | 1230 | 1137 | 1160 | 950 | 963 |
Total Liabilities | 37752 | 39394 | 39764 | 36799 | 36649 |
Total Long Term Debt | 14522 | 17296 | 18527 | 16115 | 19359 |
Long Term Debt | 14522 | 17296 | 18527 | 16115 | 19359 |
Deferred Income Tax | 991 | 1392 | 1406 | 1546 | 2056 |
Minority Interest | 219 | 222 | 219 | 213 | 198 |
Other Liabilities, Total | 6531 | 7379 | 7705 | 8062 | 6024 |
Total Equity | 36686 | 35802 | 32784 | 31088 | 30524 |
Common Stock | 24709 | 24470 | 24145 | 23853 | 23512 |
Retained Earnings (Accumulated Deficit) | 35257 | 31528 | 27627 | 25847 | 24560 |
Treasury Stock - Common | -15229 | -11822 | -10042 | -10147 | -9962 |
Unrealized Gain (Loss) | 0 | 0 | |||
Other Equity, Total | -8051 | -8374 | -8946 | -8465 | -7586 |
Total Liabilities & Shareholders’ Equity | 74438 | 75196 | 72548 | 67887 | 67173 |
Total Common Shares Outstanding | 1737.8 | 1764.08 | 1771.23 | 1762.5 | 1755.62 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 24377 | 25224 | 24845 | 24956 | 23429 |
Likvider og Kortsigtede Investeringer | 9532 | 10170 | 9907 | 9290 | 8158 |
Likvider & Lignende | 9161 | 9882 | 9594 | 8937 | 7675 |
Kortsigtede Investeringer | 371 | 288 | 313 | 353 | 483 |
Totale Tilgodehavender, Netto | 6020 | 6218 | 6408 | 7199 | 7179 |
Accounts Receivable - Trade, Net | 6020 | 6218 | 6408 | 7199 | 7179 |
Total Inventory | 6673 | 6173 | 5734 | 5899 | 5691 |
Prepaid Expenses | 2152 | 2663 | 2796 | 2568 | 2401 |
Total Assets | 73794 | 74438 | 72801 | 74202 | 74007 |
Property/Plant/Equipment, Total - Net | 9282 | 9162 | 8689 | 8818 | 8908 |
Property/Plant/Equipment, Total - Gross | 20605 | 20212 | 19306 | 19458 | 19521 |
Accumulated Depreciation, Total | -11323 | -11050 | -10617 | -10640 | -10613 |
Goodwill, Net | 22927 | 22799 | 22284 | 22744 | 23179 |
Intangibles, Net | 10006 | 10454 | 10850 | 11592 | 12225 |
Long Term Investments | 776 | 766 | 764 | 734 | 763 |
Other Long Term Assets, Total | 6426 | 6033 | 5369 | 5358 | 5503 |
Total Current Liabilities | 14530 | 15489 | 13365 | 12392 | 12647 |
Accounts Payable | 4167 | 4607 | 4133 | 4493 | 4757 |
Accrued Expenses | 6856 | 7401 | 6901 | 6715 | 6724 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2285 | 2251 | 1117 | 5 | 4 |
Other Current Liabilities, Total | 1222 | 1230 | 1214 | 1179 | 1162 |
Total Liabilities | 36784 | 37752 | 37126 | 37712 | 38608 |
Total Long Term Debt | 14615 | 14522 | 15297 | 16755 | 17086 |
Long Term Debt | 14615 | 14522 | 15297 | 16755 | 17086 |
Minority Interest | 222 | 219 | 209 | 226 | 230 |
Other Liabilities, Total | 7417 | 7522 | 8255 | 8339 | 8645 |
Total Equity | 37010 | 36686 | 35675 | 36490 | 35399 |
Common Stock | 24488 | 24709 | 24560 | 24429 | 24304 |
Retained Earnings (Accumulated Deficit) | 35868 | 35257 | 35115 | 34487 | 33295 |
Treasury Stock - Common | -15307 | -15229 | -14555 | -13720 | -13726 |
Other Equity, Total | -8039 | -8051 | -9445 | -8706 | -8474 |
Total Liabilities & Shareholders’ Equity | 73794 | 74438 | 72801 | 74202 | 74007 |
Total Common Shares Outstanding | 1738.95 | 1737.8 | 1743.57 | 1751.22 | 1750.94 |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 6933 | 7071 | 4495 | 3687 | 2368 |
Likvider Fra Driftsaktiviteter | 9581 | 10533 | 7901 | 6136 | 6300 |
Likvider Fra Driftsaktiviteter | 1254 | 1491 | 1195 | 1078 | 1100 |
Amortization | 2013 | 2047 | 2132 | 1936 | 2178 |
Ikke-Likvide Ting | 900 | 695 | 971 | 766 | 802 |
Cash Taxes Paid | 1864 | 1941 | 970 | 930 | 740 |
Likvid Rente Betalt | 563 | 544 | 549 | 677 | 845 |
Ændringer i Driftskapital | -1519 | -771 | -892 | -1331 | -148 |
Likvider fra Investeringsaktiviteter | -1740 | -2008 | -2215 | -1815 | -1356 |
Kapitaludgifter | -1777 | -1885 | -2177 | -1638 | -1394 |
Andre Investerings-Cash-Flow-Ting, Total | 37 | -123 | -38 | -177 | 38 |
Likvider fra Financieringsaktiviteter | -7636 | -5494 | -2779 | -4289 | -10391 |
Financiering af Cash-Flow-Ting | 0 | -11 | 0 | 0 | |
Total Cash Dividends Paid | -3309 | -3202 | -2560 | -2270 | -1974 |
Udstedelse (Pensionering) af Aktier, Netto | -3628 | -2044 | -158 | -420 | 33 |
Udstedelse (Pensionering) af Gæld, Netto | -699 | -248 | -50 | -1599 | -8450 |
Udenlandsk Børs Effekter | -122 | -70 | 71 | -16 | -116 |
Netto Ændring i Likviditet | 83 | 2961 | 2978 | 16 | -5563 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1318 | 6933 | 5900 | 4465 | 2447 |
Cash From Operating Activities | 1143 | 9581 | 7255 | 4475 | 2065 |
Cash From Operating Activities | 315 | 1254 | 943 | 626 | 311 |
Amortization | 491 | 2013 | 1517 | 1019 | 512 |
Non-Cash Items | 281 | 900 | 570 | 447 | 305 |
Changes in Working Capital | -1262 | -1519 | -1675 | -2082 | -1510 |
Cash From Investing Activities | -462 | -1740 | -1108 | -624 | -360 |
Capital Expenditures | -380 | -1777 | -1167 | -700 | -321 |
Other Investing Cash Flow Items, Total | -82 | 37 | 59 | 76 | -39 |
Cash From Financing Activities | -1410 | -7636 | -6179 | -4636 | -3823 |
Total Cash Dividends Paid | -890 | -3309 | -2486 | -1660 | -832 |
Issuance (Retirement) of Stock, Net | -478 | -3628 | -2984 | -2243 | -2248 |
Issuance (Retirement) of Debt, Net | -42 | -699 | -709 | -733 | -743 |
Foreign Exchange Effects | 8 | -122 | -173 | -77 | -6 |
Net Change in Cash | -721 | 83 | -205 | -862 | -2124 |
Financing Cash Flow Items |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.9022 | 154804032 | 140826 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0365 | 87581226 | -1284956 | 2023-03-31 | LOW |
Capital Research Global Investors | Investment Advisor | 4.3937 | 76404889 | -380473 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2241 | 73454220 | -1157666 | 2023-03-31 | LOW |
Capital International Investors | Investment Advisor | 3.2451 | 56430955 | 3405170 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.794 | 31196788 | 598164 | 2023-03-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.1973 | 20820152 | 6003997 | 2023-03-31 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 1.1714 | 20370034 | -3516448 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9919 | 17248522 | 765489 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.8721 | 15165569 | 261719 | 2023-03-31 | LOW |
Morgan Stanley Investment Management Ltd. (UK) | Investment Advisor | 0.8674 | 15083595 | -202533 | 2023-03-31 | LOW |
BofA Global Research (US) | Research Firm | 0.821 | 14276700 | 229604 | 2023-03-31 | LOW |
Polen Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8194 | 14249447 | -369295 | 2023-03-31 | LOW |
State Farm Insurance Companies | Insurance Company | 0.7813 | 13587118 | 0 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7577 | 13176421 | -145790 | 2023-03-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7087 | 12324688 | 44918 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6984 | 12144038 | 54953 | 2023-03-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.69 | 11998117 | -283807 | 2023-03-31 | LOW |
UBS Asset Management (Americas), Inc. | Investment Advisor | 0.6618 | 11509019 | 8668200 | 2023-03-31 | LOW |
Nuveen LLC | Pension Fund | 0.6085 | 10582312 | 377456 | 2023-03-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group530K+
Handlende
87K+
Månedlkige, aktive klienter
$46M+
Månedlig investeringsvolumen
$31M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Abbott Company profile
Om Abbott Laboratories
Abbott Laboratories beskæftiger sig med opdagelse, udvikling, fremstilling og salg af en bred vifte af sundhedsplejeprodukter. Virksomheden opererer gennem fire segmenter: Etablerede farmaceutiske produkter, diagnostiske produkter, ernæringsprodukter og medicinsk udstyr. Segmentet Established Pharmaceutical Products omfatter gastroenterologiske produkter, produkter til kvinders sundhed, kardiovaskulære og metaboliske produkter, produkter til smerter og det centrale nervesystem samt respiratoriske lægemidler og vacciner. Segmentet Diagnostic Products omfatter centrale laboratoriesystemer inden for immunoassay, klinisk kemi, hæmatologi og transfusionsmedicin; molekylærdiagnostiske polymerasekædereaktionsinstrumenter (PCR); point of care-systemer; rapid diagnostics lateral flow testing-produkter samt informatik- og automatiseringsløsninger. Segmentet Ernæringsprodukter omfatter forskellige former for modermælkserstatning og tilskudsblandinger til spædbørn, ernæringsprodukter til voksne og andre pædiatriske produkter samt andre.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Abbott Park Rd
ABBOTT PARK
ILLINOIS 60064-3500
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 520.000+ handlende over hele verden, der valgte at handle hos Capital.com